{"id":"W2349813309","doi":"10.1097/qai.0000000000001069","title":"Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults","year":2016,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"AbbVie Canada; Janssen Canada; Merck Canada; Shionogi; Sanofi; Novo Nordisk; Gilead Sciences; Daiichi Sankyo Europe; AIDS Healthcare Foundation; Bristol-Myers Squibb","keywords":"Elvitegravir; Tenofovir alafenamide; Medicine; Emtricitabine; Cobicistat; Hepatitis B; Virology; Hepatitis B virus; Coinfection; Internal medicine; Gastroenterology; Viral load; Human immunodeficiency virus (HIV); Lamivudine; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002007741,0.0004437701,0.00206025,0.001655017,0.0001096437,0.00002405044,0.0003431982,0.0001697316,0.00003926731],"category_scores_gemma":[0.007251542,0.0003164522,0.0003085342,0.001797611,0.0003162572,0.0004784341,0.0002398831,0.0001979721,0.00001007073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004140546,"about_ca_system_score_gemma":0.0004684972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001504376,"about_ca_topic_score_gemma":0.0001577085,"domain_scores_codex":[0.9942495,0.000234438,0.003318339,0.000485587,0.001008675,0.0007035074],"domain_scores_gemma":[0.9948864,0.001151122,0.002048423,0.000699168,0.0009707552,0.0002441365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003041232,0.001284786,0.4121653,0.000599427,0.0004366247,0.002766521,0.004709135,0.00003173345,0.5447873,0.0002101447,0.000329337,0.02963844],"study_design_scores_gemma":[0.008781749,0.004558671,0.9544587,0.008157731,0.00029566,0.004904611,0.0003736915,0.00003870912,0.01750636,0.0002272501,0.0002846452,0.0004122787],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920867,0.003657446,0.001351409,0.001318782,0.0002997738,0.0006906906,0.00005676292,0.00004323445,0.0004952202],"genre_scores_gemma":[0.994503,0.001693798,0.003233021,0.00004891194,0.00004224856,0.00001013341,0.000007389544,0.00007365226,0.0003878173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5422933,"threshold_uncertainty_score":0.9999288,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01246011699389881,"score_gpt":0.2537831073013661,"score_spread":0.2413229903074672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}